Quarterly Results

GKB OPHTHALMICS LTD.

NSE : NABSE : 533212ISIN CODE : INE265D01015Industry : Medical Equipment/Supplies/AccessoriesHouse : GKB
BSE92.11-1.82 (-1.94 %)
PREV CLOSE ( ) 93.93
OPEN PRICE ( ) 93.93
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1080
TODAY'S LOW / HIGH ( )90.21 95.20
52 WK LOW / HIGH ( ) 74.1127.95
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
Audited
UnAudited
UnAudited
Net Sales
240.38
204.01
222.58
199.63
Total Expenditure
245.22
206.99
209.03
203.53
PBIDT (Excl OI)
-4.84
-2.98
13.55
-3.90
Other Income
3.46
3.12
3.5
2.31
Operating Profit
-1.38
0.12
17.05
-1.59
Interest
4.4
4.55
4.35
4.34
Exceptional Items
NA
NA
NA
NA
PBDT
-5.78
-4.42
12.7
-5.93
Depreciation
7.34
7.33
7.16
16.25
Profit Before Tax
-13.12
-11.75
5.54
-22.18
Tax
0.01
0.01
0.01
-1.01
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-13.13
-11.76
5.53
-21.17
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-13.13
-11.76
5.53
-21.17
Minority Interest
1.88
0.24
-0.2
1.62
Shares of Associates
-1.28
-0.18
-0.1
0.38
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-12.52
-11.68
5.24
-19.17
Equity Capital
50.41
50.41
50.41
50.41
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
-2.48
-2.31
1.03
-3.80
Calculated EPS (Annualised)
-9.93
-9.26
4.15
-15.21
No of Public Share Holdings
2475926
2476928
2057459
2062092
% of Public Share Holdings
49.12
49.14
40.82
40.91
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-2.01
-1.46
6.08
-1.95
PBIDTM%
-0.57
0.06
7.66
-0.79
PBDTM%
-2.40
-2.16
5.70
-2.97
PBTM%
-5.45
-5.75
2.48
-11.11
PATM%
-5.46
-5.76
2.48
-10.60
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.